Abstract
Mitotic kinesin Eg5 is an ATPase driven motor protein and it plays crucial role for spindle segregation during Eukaryotic cell division. Kinesin Eg5 is over expressed in cancer cell. Therefore, kinesin Eg5 is considered as a target of the cancer therapy. There are several types of well-known compounds have been utilized as Eg5 inhibitors, e.g. Monastrol, STLC (S-trityl-L cysteine), Ispinesib and so on. Althought the structure of these inhibitors are not conserved and displayed diversity. They bind to the same pocket of Eg5 composed of helix α2, helix α3 and loop 5.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
